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Hyaluronan-binding protein 1 (HABP1), a ubiquitous
multifunctional protein, interacts with hyaluronan, globular
head of complement component 1q (gC1q), and clustered
mannose and has been shown to be involved in cell sig-
nalling. In vitro, this recombinant protein isolated from
human fibroblast exists in dierent oligomeric forms, as is
evident from the results of various independent techniques
in near-physiological conditions. As shown by size-exclu-
sion chromatography under various conditions and glu-
taraldehyde cross-linking, HABP1 exists as a noncovalently
associated trimer in equilibrium with a small fraction of a
covalently linked dimer of trimers, i.e. a hexamer. The
formation of a covalently-linked hexamer of HABP1
through Cys186 as a dimer of trimers is achieved by thiol
group oxidation, which can be blocked by modification of
Cys186. The gradual structural transition caused by cyste-
ine-mediated disulfide linkage is evident as the fluorescence
intensity increases with increasing Hg2+ concentration until
all the HABP1 trimer is converted into hexamer. In order to
understand the functional implication of these transitions,
we examined the anity of the hexamer for dierent
ligands. The hexamer shows enhanced anity for hyal-
uronan, gC1q, and mannosylated BSA compared with the
trimeric form. Our data, analyzed with reference to the
HABP1/p32 crystal structure, suggest that the oligomer-
ization state and the compactness of its structure are factors
that regulate its function.
Keywords: clustered mannose; hyaluronan; hyaluronan-
binding protein 1 (HABP1); oligomerization; p32.
Hyaluronan-binding protein 1 (HABP1), a 68-kDa
protein, was originally purified as a novel receptor of
hyaluronan, an important component of the extracellular
matrix [1]. Subsequently, we characterized the protein and
confirmed its localization on the cell surface [2] and its
role in cell adhesion and tumour invasion [3], sperm
maturation, and motility [4,5]. The role of this protein in
hyaluronan-mediated cellular signalling is well document-
ed, as hyaluronan binding to lymphocyte and hyaluronan-
mediated lymphocyte aggregation were inhibited by
pretreatment of the cells with antibodies to HABP1 [6].
This is further strengthened by the observation of
enhanced phosphorylation of HABP1 and increased
formation of inositol trisphosphate and phospholipase
C-c in hyaluronan-supplemented cells, which have been
shown to be inhibited by pretreatment with antibodies to
HABP1 [7]. As a continuation of this study, the cDNA
encoding HABP from human skin fibroblast has been
cloned and sequenced [8]. The presence of the hyaluronan-
binding motif was confirmed and the overexpressed
protein subsequently shown to bind hyaluronan. The
gene encoding this protein has been assigned to human
chromosome 17p12-p13 and has been named HABP1 [9].
A computer search of the sequence encoding HABP1
revealed identity with p32, a protein copurified with
splicing factor SF2 [10], and with the receptor for globular
head of complement subcomponent C1q (gC1qR) [11],
and substantial homology (92%) with YL-2, the HIV-rev
binding murine homologue [12,13].
Recent studies on p32/HABP1 show its localization in
various cellular compartments including mitochondria,
nucleus, cytosol and the cell surface in different cell types
[14,15]. In addition, interaction of p32/HABP1 with a
number of proteins, including hepatitis C virus core protein,
which inhibits T-lymphocyte proliferation [16], Staphylo-
coccus aureus protein A [17],Listeria monocytogenes protein
In1B [18], high-molecular-mass kininogen [19], clustered
mannose [20] and lamin B receptor [21] give new dimensions
to the actual functional role of p32/HABP1. The crystal
structure of p32/HABP1 shows a solvent-exposed hyaluro-
nan-binding motif in its trimeric assembly [22]. Interaction
of this protein with many different ligands suggests the
existence of different molecular forms. In addition to a
tightly coupled receptor–ligand interaction, its biological
specificity and function are regulated by intricate mech-
anisms involving conformational transitions in several
proteins [23]. However, the structural flexibility of HABP1
in solution has not been addressed adequately. In this study,
we have examined the structural transitions of HABP1 and
the effects of these on affinity for different ligands.
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M A T E R I A L S A N D M E T H O D S
Materials
EAH–Sepharose 4B, Superose 6 columns, Sephadex G-25
and molecular mass markers were obtained from Phar-
macia Biotech Inc. (Uppsala, Sweden). The Protoblot
Western-blot system was purchased from Promega Corp.
(Madison, WI, USA). ImmunoPure Biotin-LC-Hydrazide
was purchased from Pierce (Rockford, IL, USA). Com-
plement component 1q (C1q) and the other chemicals
were obtained from Sigma Chemicals Co. (St Louis, MO,
USA).
Purification of HABP1 and preparation of its polyclonal
antibodies
HABP1 was purified to homogeneity using ion-exchange
chromatography on a Mono Q HR 10/10TM column
(Pharmacia), interfaced with a Pharmacia FPLCTM system
using a linear gradient of 0–1 M NaCl in 20 mM Hepes,
pH 7.5, containing 1 mM EDTA, 1 mM EGTA, 5%
glycerol and 0.2% 2-mercaptoethanol, followed by hyal-
uronan–Sepharose affinity column chromatography as
reported previously [8] and size-exclusion chromatography
in 10 mM phosphate-buffered saline containing 150 mM
NaCl. Antibodies to purified HABP1 were raised in a New
Zealand White rabbit [8].
Electrophoresis and immunodetection
Gradient or linear polyacrylamide slab gel electrophoresis
was carried out by the procedure of Laemmli [24].
HABP1 that had undergone different treatments was also
subjected to either 9% nondenaturing PAGE or
pore-limiting gel electrophoresis on polyacrylamide gel
of gradient 7–24% as described previously, with the
modification of 0.005% SDS in Tris/glycine running
buffer, pH 8.3 [25,26]. Separated proteins were trans-
ferred to nitrocellulose membrane by applying current at
0.8 mAÆcm)2Æh)1 in a semidry transfer unit (Pharmacia);
they were immunodetected using rabbit anti-HABP1 IgG
(1 : 1000 dilution) visualized by the nitro blue tetrazolium
(NBT)/5-bromo-4-chloro-3-indolyl phosphate (BCIP)
detection system using alkaline phosphatase conjugated
goat anti-(rabbit IgG) Ig as secondary antibody (1 : 7500
dilution).
Gel-permeation chromatography of HABP1
Gel-permeation chromatography was carried out on a
Pharmacia Superose 6TM analytical column (1 · 30 cm)
interfaced with an FPLCTM system at a flow rate of
0.3 mLÆmin)1. The buffer was 10 mM phosphate, pH 7.2,
with or without 0.1% (v/v) 2-mercaptoethanol and/or
0.1% (w/v) sodium lauryl sulfate, keeping the ionic
concentration constant at 150 mM NaCl. The standard
molecular mass markers of known molecular mass
and Stokes radius, alcohol dehydrogenase (150 kDa,
46 A˚); BSA (67 kDa, 35.5 A˚); ovalbumin (43 kDa, 30.5 A˚)
chymotrypsinogen (25 kDa, 20.9 A˚) and ribonuclease A
(13.7 kDa, 16.4 A˚) were independently run in each case.
Chemical modification of HABP1
Chemical modification of the cysteine residue was carried
out as reported previously [27]. In brief, HABP1
(1 mgÆmL)1) was treatedwith iodoacetamide and iodoacetic
acid (1 : 3 molar ratio) in 50 mM Tris/HCl, pH 8.5,
containing 1 mM EDTA, 1 mM EGTA, 10 mM dithiothre-
itol and 8 M urea at room temperature for 30 min. This
reaction mixture was passed through a Sephadex G-25
column, and the protein fractions were pooled and concen-
trated for use as cysteine-modified HABP1.
Covalent cross-linking of HABP1 subunits
To HABP1 (0.2 lM) in 10 mM phosphate buffer, pH 7.2,
containing 150 mM NaCl, an aliquot of 25% (mass/
volume) glutaraldehyde was added to a final concentra-
tion of 1%. This sample was incubated at 25 °C for
5 min; the cross-linking reaction was then quenched by
adding 30 mM 1-mercaptoethanol [28]. After 20 min of
incubation, 10% (w/v) aqueous sodium deoxycholate
stock was added to the reaction mixture to a final
concentration of 0.3%. The pH of the reaction mixture (in
10 mM phosphate, 150 mM NaCl, pH 7.2) was lowered to
2.0–2.5 by the addition of concentrated orthophosphoric
acid, which resulted in coprecipitation of cross-linked
HABP1 with sodium deoxycholate. After centrifugation
(13 327 g, 4 °C), the precipitate was redissolved in 0.1 M
Tris/HCl, pH 8.0, containing 1% SDS and 0.1%
2-mercaptoethanol and heated at 90–100 °C for 3 min.
This sample was separated by SDS/PAGE (12.5% gel),
transferred to nitrocellulose membrane, immunodetected
using rabbit anti-HABP1 IgG, and visualized by the
NBT/BCIP detection system.
Copper–phenanthroline-induced disulfide linkage
of HABP1
Catalytic oxidation of the thiol group of HABP1 was
achieved with a copper–phenanthroline complex [29].
Purified HABP1 (1 mgÆmL)1) in NaCl/Pi was incubated
with one-tenth reaction volume of 2.5 mM CuSO4Æ5H2O
and 5 mM 1,10-phenanthroline. The mixture was gently
vortex-mixed under aerobic conditions, incubated for
10 min at room temperature, and passed through a
Sephadex G-25 column; protein-containing fractions were
pooled and concentrated using a CentriconTM membrane
(10-kDa cut-off). The concentrated protein was mixed with
native-PAGE sample buffer and analyzed on a native 9%
polyacrylamide gel. The same sample was analyzed for
copper on a PU2000X Philips atomic absorption spectro-
meter with a sensitivity of  0.3 lM using copper nitrate as
standard solution.
HgCl2-induced disulfide linkage of HABP1
HgCl2-induced disulfide linkage of two cysteine residues was
achieved by a previously described procedure [30]. Purified
HABP1 (1 mgÆmL)1) in NaCl/Pi was incubated with HgCl2
at a concentration of 50 lM at 30 °C for 10 min. Aliquots
were mixed with native-PAGE sample buffer and analyzed
by native PAGE (9% gel) or pore-limiting PAGE.
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Estimation of thiol group
The Ellman assay was performed to determine the free thiol
group in HABP1, cysteine-modified and copper–phenan-
throline-oxidized HABP1 as previously described [27]. In
brief, 800 lL protein solution (10 lM) in 10 mM phosphate
buffer containing 150 mM NaCl, 1 mM EDTA and 6 M
guanidinium hydrochloride (pH 7.2) was placed in the
sample compartment of a spectrophotometer (Cary100;
Varian Inc.) interfaced with a Peltier temperature controller;
the reference compartment contained buffer only. The
absorbance difference at 412 nm was set to zero at 25 °C.
Then, 40 lL 5,5¢-dithionitrobenzoic acid was added to the
sample and reference compartments of each cuvette, and the
contents thoroughly mixed. The absorbance difference at
412 nmwas immediately monitored, and the value recorded
when there was no further increase. The thiol molar
concentration was calculated from the increased absorbance
caused by 5,5¢-dithionitrobenzoic acid taking the molar
absorbance of the thionitrobenzoate anion to be
e412  13 700 in 6 M guanidinium hydrochloride.
Fluorescence measurement
HgCl2-treated HABP1 was passed through a Sephadex
G-25 column to remove free Hg2+ ion and concentrated
using a CentriconTM membrane (10-kDa cut-off) in 20 mM
Tris/HCl, pH 7.5, buffer to 0.2 mgÆmL)1 so that A282 £ 0.1
to avoid any inner-filter effect. the sample was excited at
282 nm; the excitation maxima of HABP1 and emission
were collected at 347 nm on a PerkinElmer LS50B
fluorimeter. The background emission intensity was sub-
tracted using the buffer alone.
Biotinylation of hyaluronan, D-mannosylated BSA
and HABP1, and their use in binding assays
Hyaluronan was biotinylated by the procedure of Yang
et al. [31]. HABP1 and the polypeptide backbone of
mannosylated BSA were biotinylated according to the
instructions given for protein biotinylation in the manufac-
turer’s (Pierce) guide, and used for the ligand-binding assay.
The bound biotinylated hyaluronan, mannosylated BSA or
HABP1 were probed with horseradish peroxidase-conju-
gated streptavidin (1 : 7500) and visualized with 2,2¢-azino-
bis(3-ethylbenzthiazoline-6-sulfonic acid). Alternatively, for
C1q binding, it was coated on a microtitre plate and
incubatedwith different oligomeric forms ofHABP1 for 1 h
at room temperature and probed with anti-HABP1 IgG; it
was detected with horseradish peroxidase-conjugated goat
anti-(rabbit IgG) Ig and visualized with 2,2¢-azino-bis
(3-ethylbenzthiazoline-6-sulfonic acid).
R E S U L T S
Existence of two oligomeric forms of HABP1
The oligomeric states of HABP1 were investigated under
native conditions by immunoblot analysis using antibody
raised against purified rabbit HABP1. As shown in Fig. 1,
different amounts of purified HABP1 in the absence of any
reducing agent were subjected to native PAGE (9% gel),
transferred to a nitrocellulose membrane, and immuno-
detected with anti-HABP1 IgG. It showed two bands, a
broad and relatively prominent lower band (I) and a fairly
sharp minor higher band (II). The emergence of the higher
band seems to be concentration dependent in vitro, as it
appears only in lanes 2 and 3 (Fig. 1), in which the amount
of protein loaded was 5 and 10 lg, respectively. The
electrophoretic mobility of band II seems to be slightly less
than double that of band I. This is because HABP1 has a
larger than average number of polar amino-acid residues
and therefore it shows anomalous migration on PAGE.
Dimerization of trimers may also change the size and
conformation of the molecule, and this may be one reason
why a dimer of trimers does not seem tomigrate at twice the
molecular mass of trimeric HABP1. The concentrations of
the two oligomeric populations, estimated by densitometric
comparison of the intensities of the two bands, were
observed to be in the ratio of  12 : 1.
Studies on the oligomeric transitions of HABP1 under
native, reducing, and denaturing conditions were carried out
by analysing their relative molecular masses using gel-
permeation chromatography. Under native conditions
(Fig. 2A, dotted line), HABP1 showed a major peak
corresponding to a protein of apparent molecular mass
68 kDa (marked III, Fig. 2A) and a minor peak of protein
corresponding to an apparent molecular mass of 136 kDa
(marked IV, Fig. 2A). Thus, HABP1 exists in solution
predominantly as a trimeric (68 kDa)molecule with aminor
hexameric (136 kDa) form, assuming a cDNA-derived
Fig. 1. HABP1 exists in two dierent oligomeric forms in solution.
HABP1 (2 lg, lane 1; 5 lg, lane 2; 10 lg, lane 3) was electrophoresed
on 9% native polyacrylamide gel in the absence of reducing agents
using a discontinuous buer system, and transferred to nitrocellulose
membrane, probed with anti-HABP1 IgG, and detected using alkaline
phosphatase conjugate of goat anti-rabbit IgG and an NBT/BCIP
detection system. The two oligomeric forms of HABP1 are marked
I and II. Molecular mass standards are shown on the left.
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molecular mass of 23801.1 Da for the monomer. HABP1
exists in different oligomeric forms under reducing condi-
tions comparedwith native conditions. As shown in Fig. 2A
(solid line), the protein in the presence of 0.1%
2-mercaptoethanol exhibited a different elution profile,
although it showed two peaks, one minor (marked I,
Fig. 2A) and the other major (marked III, Fig. 2A). The
protein corresponding to the major peak in this case has a
molecular mass of 68 kDa, and the protein of the minor
peak has a molecular mass of 25 kDa, corresponding to the
monomeric size of HABP1. Gel-permeation experiments
carried out in the presence of 0.1% SDS and 0.1%
2-mercaptoethanol (dotted line, Fig. 2B) showed a single
molecular form corresponding to a molecular mass of
25 kDa (marked I) on the basis of protein standards run
under identical conditions. This clearly implies that the
protein remains in the monomeric form under reducing and
denaturing conditions. However, in the absence of
2-mercaptoethanol, the 25-kDa protein becomes very small
and a new form corresponding to 46 kDa (marked II,
Fig. 2B) appears, suggesting that, under nonreducing
denaturing conditions, the protein predominantly exists in
the dimeric form. On the Superose 6 column, the major
peak (marked III) was eluted with a Kav of 0.499, which is
equivalent to a Stokes radius of 36.2 A˚, and the minor peak
(marked IV) was eluted with a Kav of 0.412, which is
equivalent to a Stokes radius of 46.0 A˚.
To stabilize the potential oligomeric states of HABP1, the
covalent cross-linker, glutaraldehyde, was incubated with
HABP1 as described in Materials and methods and
analysed under reducing conditions by SDS/PAGE; this
was followed by transfer to a nitrocellulose membrane and
immunodetection using anti-HABP1 IgG (Fig. 3A). It
shows conversion of most of the monomeric band at
34 kDa to a higher species with a relative molecular mass of
nearly 70 kDa. However, a smear at  20–25 kDa was
consistently observed, which represents uncross-linked
HABP1 monomer corresponding to the sequence-derived
molecular mass that may arise from modified electrophor-
etic mobility as a result of neutralization of positive charges
of the lysine side chain by glutaraldehyde.
Oligomeric transitions
As is evident from the cDNA sequence, each protomer has
only one cysteine (Cys186) in the polypeptide chain of
HABP1 [8]. Therefore, the trimer has three free cysteine
residues, which can form disulfide bonds by associationwith
a set of three cysteine residues from another trimer leading
to formation of a hexamer. However, it is also possible that,
under air oxidation, the cross-linking of these cysteine
residues may lead to the formation of a small proportion of
hexamer. To investigate this, HABP1 was incubated with
the thiol-group-oxidizing agent, Cu2+)1,10-phenanthro-
line. There was a 100% shift of band I to band II (Fig. 3B,
lane 1).
To confirm that the trimer–hexamer transition does
indeed occur through disulfide linkage of cysteine residues,
experiments were carried out with cysteine-modified
HABP1. Gel-permeation chromatography of cysteine-
modified HABP1 (Fig. 4A) shows a single peak corre-
sponding to 68 kDa. The effect of Cu2+ and Hg2+ ions on
cysteine-modified HABP1 was examined by pore-limiting
PAGE to examine the role of the metal ion, if any, in
disulfide bond formation. Native, cysteine-modified and
HgCl2-treated HABP1 were separated, transferred to
nitrocellulose membrane, and probed with anti-HABP1
IgG. The data indicate dimerization of trimers, which is
inhibited by cysteine modification (Fig. 4B, lane 4). To
examine the molecular transition of HABP1 by HgCl2,
nativeHABP1was treatedwith increasing concentrations of
Hg2+ and subsequently desalted on a Sephadex G-25
column before monitoring of their intrinsic fluorescence.
The gradual increase in fluorescence intensity with increas-
ing Hg2+ concentration until all the trimeric HABP1 was
presumably converted into hexameric species indicates a
Fig. 2. Oligomeric states of HABP1 in solution. (A) Gel-permeation chromatography of HABP1 (1.2 mgÆmL)1) on a Superose 6 column
(1 · 30 cm) in NaCl/Pi/0.15 M NaCl, pH 7.2 (broken line) and NaCl/Pi/0.15 M NaCl, pH 7.2, containing 0.1% 2-mercaptoethanol (solid line) at
a flow rate of 0.3 mLÆmin)1. The column was calibrated using molecular mass standards run under similar conditions: 1, alcohol dehydrogenase;
2, BSA; 3, ovalbumin; 4, chymotrypsinogen; 5, ribonuclease A. The estimation of the molecular mass (Mr) of the oligomer, indicated by arrows, is
shown in the inset. (B) Gel-permeation chromatography of HABP1 (1.2 mgÆmL)1) on a Superose 6 column (1 · 30 cm) in NaCl/Pi/0.15 M NaCl,
pH 7.2, containing 0.1% SDS (solid line) and 0.1% SDS and 0.1% 2-mercaptoethanol (broken line). The column was calibrated using the same
molecular mass standards under the above conditions. The molecular mass (Mr) of standards indicated by arrows is shown in the inset and
numbered 1, 2, 3, 4 and 5, respectively. The peaks marked I, II, III and IV represent monomer, dimer, trimer and hexamer, respectively.
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change in the microenvironment around tryptophan as a
result of trimer dimerization (Fig. 4C).
Attempts to generate the dimer of trimers using cysteine-
modified HABP1 and copper–phenanthroline as oxidant
also failed; however, the unmodified form was observed to
dimerize after treatment with 50 lM copper–phenanthroline
(data not shown). To examine the role of metal ions in
trimer dimerization, we measured the amount of copper
bound to the dimer of trimers, if any, using atomic
absorption spectroscopy. A protein concentration of
50 lM was used for detection of the metal ion. The data
show that the copper content of this preparation is less than
15 : 1 (protein to metal ion molar ratio) keeping the
detection limit of the instrument in the mind. The presence
of any copper below this level is insignificant as far as trimer
dimerization is concerned. Thus, the role of cysteine in
trimer dimerization seems to be unambiguous.
To further establish the role of the cysteine residue in the
generation of dimers of trimers, the free thiols were
determined in HABP1, copper–phenanthroline-induced
dimer of trimers, and cysteine-modified HABP1. No free
thiol groups were available in copper–phenanthroline-
induced dimer of trimers and cysteine-modified HABP1,
but one free thiol group per HABP1monomer was detected
in reduced unmodified HABP1.
Oligomeric transitions and ligand affinity
The affinity of the trimeric and hexameric forms of HABP1
for its various ligands, e.g. hyaluronan, D-mannosylated
BSAandgC1q,wasanalyzedbyELISA.HgCl2 and copper–
phenanthroline treatment of HABP1 resulted in trimer to
hexamer conversion, which could be blocked by cysteine
modification. These oligomeric forms of HABP1 were
separated using size-exclusion chromatography and quanti-
tatively analyzed for binding to biotinylated hyaluronan,
biotinylated D-mannosylated BSA, and gC1q. The hexamer
generated by thiol-group oxidation of native HABP1 had
greater affinity for its ligand than native and cysteine-
modifiedHABP1or nativeHABP1 (Fig 5A,B,C).However,
the cysteine-modified HABP1, which cannot be converted
into hexamer by thiol-group oxidation, showed similar
affinity for its ligands to theunmodifiedprotein.The trimeric
form of HABP1 had less affinity than the hexamer. The
differential binding of trimer and hexamer was more
pronounced in the case of hyaluronan than gC1q or
mannosylated BSA. Therefore, the dissociation constant
for the hyaluronan–HABP1 interaction was calculated by
Scatchard plot analysis from the data in Fig. 5A, taking the
average molecular mass of hyaluronan to be 10 MDa
(Fig. 5D). The apparent dissociation constant of the
hexamer was found to be 0.05 · 10)9 compared with
0.1 · 10)9 for the trimer.
D I S C U S S I O N
In this study, we demonstrate the presence of different
oligomeric forms of HABP1: monomer, noncovalently
linked trimer, and cysteine-linked dimer of trimers.
Interestingly, all these species of HABP1 have different
affinities for hyaluronan, suggesting a possible role for
different oligomeric states of HABP1 in hyaluronan
signalling. The major peak on gel-filtration chromatogra-
phy corresponds to the trimer of HABP1, with an
estimated molecular mass of 68 kDa. This is also identical
with the gel-filtration-derived molecular mass of HABP1
purified from tissue [3]. A small proportion of the protein
exists in the hexameric state in solution through Cys186-
linked disulfide bonds. However, the crystal structure of
HABP1 in the presence of 600 mM NaCl under reducing
conditions suggested that HABP1 is a trimeric protein
[22]. This is in agreement with our data in solution under
Fig. 3. Evidence for oligomeric structural
transition of HABP1. (A) HABP1 was
incubated with glutaraldehyde, as described in
Materials and methods. The cross-linked
samples were analyzed by SDS/PAGE (12.5%
gel). The electrophoresed gel was transferred
to nitrocellulose membrane, probed with
anti-HABP1 IgG, and detected using alkaline
phosphatase conjugate of goat anti-rabbit IgG
and an NBT/BCIP detection system Lane 1,
untreated HABP1; lane 2, treated with
glutaraldehyde. Themolecularmass standards
are shown on the left. (B) HABP1 was incu-
bated with CuSO4 and 1,10-phenanthroline
(1 : 2 molar ratio) for disulfide linkage
following the earlier procedure. HABP1 alone
(lane 2), and in the presence of the copper–
phenanthroline complex (lane 1) were
analyzed on a 9% nondenaturing gel. The gel
was transblotted on a nitrocellulose
membrane and probed with anti-HABP1 IgG.
Molecularmassmarkers are shown on the left.
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similar conditions, in which we find the majority of the
protein in the trimeric form.
There was a significant change in shape and size of
HABP1 on SDS binding as well as in the presence of
2-mercaptoethanol as observed in gel-filtration experiments.
It was in the monomeric state under reducing and denatur-
ing conditions, and in the dimeric state (with a minor
component of monomer) under nonreducing denaturing
conditions. The reason for the predominantly dimeric form
under these conditions is the oxidative atmosphere of the
experiment, in which unfolded monomer becomes dimer-
ized through cysteine disulfide bond formation. On the
other hand, under reducing nondenaturing conditions, it is
predominantly present as a trimer with a small proportion
of monomer, although under native conditions, it predom-
inantly remains as a trimer with a small proportion of
hexamer. This clearly suggests that the trimer is stabilized
through non-covalent interactions, and the formation of
hexamer from trimer is facilitated by the disulfide bond
formation between the subunits.
Sequence analysis confirms the presence of only one
cysteine (Cys186) residue in HABP1 isolated from human
Fig. 4. Dimerization of trimeric HABP1 through Cys186. (A) Gel-permeation chromatography of cysteine-modified HABP1 (1 mgÆmL)1) on a
Superose 6 column (1 · 30 cm) in 10 mM phosphate buer containing 150 mM NaCl, pH 7.2, at a flow rate of 0.3 mLÆmin)1. The column was
calibrated as described in Fig. 2. (B) Pore-limiting gel electrophoresis of HABP1 and Cys186-modified HABP1. Equal amounts of HABP1 treated
with 50 lMHgCl2 (lane 1), nativeHABP1 (lane 2), modifiedHABP1 treated with 50 lMHgCl2 (lane 3), modifiedHABP1 (lane 4), and SDS-treated
HABP1 (lane 5) were separated on a 7–24% polyacrylamide gradient gel using 0.005% SDS in Tris/glycine running buer, pH 8.3, as described in
Materials and methods. The gel was transblotted and probed with anti-HABP1 IgG and detected using goat anti-rabbit IgG and alkaline
phosphatase conjugate. (C) Change in fluorescence emission intensity at 347 nm. HABP1 was treated with various amounts of HgCl2 and then
desalted on a Sephadex G-25 column as described in Materials and methods.
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and mouse [22]. Oxidation of noncovalent trimer induced
by HgCl2 or copper–phenanthroline shows the conversion
of HABP1 into the hexameric species in buffer of low ionic
strength. However, cysteine-modified HABP1 remained
trimeric even after treatment with Hg2+ or Cu2+ unlike
the native HABP1, clearly establishing the role of cysteine
in trimer to hexamer transition. This observation is further
strengthened by the absence of bound copper in the dimer
of trimers of native HABP1 induced by copper–phen-
anthroline. Hence, it may be postulated that Cu2+ acts
only as an oxidant and does not participate directly in
dimer formation. In support of this, the higher level of
trimer to hexamer association induced by HgCl2 was also
evident from the fluorescence analysis. HABP1 polypep-
tide sequences of higher eukaryotes (human and mouse)
show three conserved tryptophans, of which Trp109 and
Trp219 face the relatively hydrophobic side of the
molecule and Trp233 resides on the negatively charged
protein surface [22]. The gradual increase in fluorescence
intensity of HABP1, separated by size-exclusion chroma-
tography after pretreatment with increasing concentrations
of Hg2+ indicates a gradual change in the microenviron-
ment around tryptophan as the result of transition from
trimer to hexamer. Dimerization of trimeric HABP1 may
lead to exposure of tryptophan to a nonpolar/hydrophobic
environment, which in turn may lead to an increase in
emission intensity at 347 nm [32]. In contrast with this, the
crystal structure shows that Cys186 is not easily accessible
for oligomerization induced by an intertrimer disulfide
bond. The crystal structure of HABP1/p32 determined in
the presence of 600 mM NaCl, 1 mM EGTA and 1 mM
EDTA is compact compared with its form in native
conditions, near pH 7.2 and physiological ionic strength. It
is apparent from our observation that the hydrodynamic
radius of HABP1/p32 near physiological pH and ionic
strength is greater (36.2 A˚) than that of the crystal
structure (34.0 A˚). Such an increase in hydrodynamic
volume may expose Cys186 residues, enabling them to
form S–S bonds.
Under native conditions, at pH 7.2, HABP1 has a
hydrodynamic radius of 36.2 A˚ as the major species. The
Cys186 residue responsible for covalent association of two
trimers through disulfide bond formation is not accessible in
the crystal structure. The state of HABP1 with the larger
hydrodynamic radius may be different from the crystal
structure, as the changes associated with the addition of
trace amounts of bivalent cations may represent a structural
state in which this cysteine is exposed to the solvent,
Fig. 5. Higher anity of the hexameric form of HABP1 for its ligand. Dierential ligand anity of HABP1 oligomer purified by size-exclusion
chromatography. Starting from 500 ng and using serial dilution, dierent oligomeric forms of HABP1 were coated on an ELISA plate in triplicate
and probed with (A) biotinylated hyaluronan (HA), (B) biotinylated D-mannosylated BSA (DMA) and detected with streptavidin–horseradish
peroxidase conjugate; (·) HABP1 alone; (d) HABP1 treated with 50 lM HgCl2; (j) cysteine-modified HABP1 treated with HgCl2; (s) BSA. (C)
C1q was coated on an ELISA plate starting with 500 ng using serial dilution and incubated with dierent oligomeric forms of HABP1; they were
then probed with rabbit anti-HABP1 IgG. The bound HABP1 was probed with alkaline phosphatase-conjugated goat anti-rabbit IgG (1 : 7500)
and visualized by the 2,2¢-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) detection system. (·) HABP1 alone; (d) HABP1 treated with 50 lM
HgCl2; (j) cysteine-modified HABP1 treated with HgCl2; (s) BSA. BSA was used as negative control. Each data point is representative of three
similar sets of experiment. (D) Scatchard plot analysis of the anity of dierent oligomeric forms of HABP1 for hyaluronan. (s) Trimer; (d)
hexamer.
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facilitating inter-trimeric disulfide bond formation. HABP1
with a larger hydrodynamic radius and solvent-exposed
cysteine residue under physiological conditions may corre-
spond to the expanded structure [33].
The existence of HABP1 in different oligomeric states
has functional implications. Disulfide-mediated hexamer
formation leads to a compact oligomeric structure, which
is shown to have the highest ligand affinity. The mono-
meric form binds weakly to hyaluronan compared with the
trimeric form. The low affinity of the HABP1 monomer
may be explained by the presence of an additional glutamic
acid residue (E127) in the putative hyaluronan-binding
motif. Structural analysis of crystallographic data submit-
ted to the protein data bank (PDB) with molecular ID
1P32, a protein that is 100% homologous with HABP1
(synonyms C1QBP, gC1qR, p32 and HABP1), reveals that
the peptide segment K119 to K128 of each monomer in a
trimeric assembly is usually accessible to the solvent.
However, E127 of each monomer in a trimeric assembly is
completely buried, as it is involved in salt bridge formation
with R246 and K174 and the average distances of the two
side chains of R246 and K174 from E127 are 3.2 A˚ and
2.8 A˚, respectively. Thus, in the trimer, there are more
positive charges clustering around the hyaluronan-binding
motif, K119–K128. The dimerization of HABP1 trimers
presumably allows multiple copies of HABP1 to interact
with its ligand more strongly. However, the affinity of the
dimer of trimers for D-mannosylated BSA and gC1q is
similar to that of the trimer, suggesting that different
mechanisms are involved in the binding of HABP1 and its
different ligands. Protomer oligomerization is known to
have an important role in ligand binding, signal transduc-
tion, and protein function. In the case of serum mannose-
binding protein, its complement-dependent haemolytic
activity is regulated by oligomeric transition [34]. Similarly,
the hyaluronan-binding activity of CD44, another member
of the hyaladherin family, has been linked to cellular
activation. Phorbol 13-myristate 12-acetate is known to
induce clustering of CD44 followed by disulfide-mediated
dimerization, which is critical for binding of high levels of
hyaluronan [35,36]. A similar role for cysteine-mediated
oligomerization in HABP1 in signal transduction and
hyaluronan binding can be expected as HABP1 is reported
to be involved in hyaluronan-induced signal transduction
[5–7]. So the intricate regulatory mechanism of cellular
signalling by oligomerization of HABP1 may have func-
tional implications in the cell.
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